Publications
274 results found
Bhangal G, Halford S, Wang J, et al., 2000, Expression of the multidrug resistance gene in human prostate cancer, UROLOGIC ONCOLOGY, Vol: 5, Pages: 118-121, ISSN: 1078-1439
- Author Web Link
- Cite
- Citations: 38
Wang J, Waxman J, 2000, Chemotherapy for prostate cancer, UROLOGIC ONCOLOGY, Vol: 5, Pages: 93-96, ISSN: 1078-1439
- Author Web Link
- Cite
- Citations: 10
Prior T, Waxman J, 2000, Localised prostate cancer: can we do better? There have been some advances in local control, but little impact on survival, BRITISH MEDICAL JOURNAL, Vol: 320, Pages: 69-70, ISSN: 0959-8138
- Author Web Link
- Cite
- Citations: 8
Stubbs AP, Abel PD, Golding M, et al., 1999, Differentially expressed genes in hormone refractory prostate cancer - Association with chromosomal regions involved with genetic aberrations, AMERICAN JOURNAL OF PATHOLOGY, Vol: 154, Pages: 1335-1343, ISSN: 0002-9440
- Author Web Link
- Cite
- Citations: 31
Wang Q, Stamp GWH, Powell S, et al., 1999, Correlation between androgen receptor expression and FGF8 mRNA levels in patients with prostate cancer and benign prostatic hypertrophy, JOURNAL OF CLINICAL PATHOLOGY, Vol: 52, Pages: 29-34, ISSN: 0021-9746
- Author Web Link
- Cite
- Citations: 14
Halford S, Waxman J, 1998, The management of carcinoid tumours, QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, Vol: 91, Pages: 795-798, ISSN: 1460-2725
- Author Web Link
- Cite
- Citations: 5
Syrigos KN, Harrington K, Waxman J, et al., 1998, Altered γ-catenin expression correlates with poor survival in patients with bladder cancer, JOURNAL OF UROLOGY, Vol: 160, Pages: 1889-1893, ISSN: 0022-5347
- Author Web Link
- Cite
- Citations: 67
Bower M, Roylance R, Waxman J, 1998, Immunotherapy for renal cell cancer, QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, Vol: 91, Pages: 597-602, ISSN: 0033-5622
- Author Web Link
- Cite
- Citations: 4
Syrigos KN, Karayiannakis A, Harrington K, et al., 1998, Abnormal expression of the E-cadherin-catenin complex correlates with poor prognosis in bladder cancer patients., EUROPEAN JOURNAL OF CANCER, Vol: 34, Pages: S19-S19, ISSN: 0959-8049
Bower M, Ma R, Savage P, et al., 1998, British urological surgery practice: 2. Renal, bladder and testis cancer, BRITISH JOURNAL OF UROLOGY, Vol: 81, Pages: 513-517, ISSN: 0007-1331
- Author Web Link
- Cite
- Citations: 9
Waxman J, Roylance R, 1998, New drugs for prostate cancer?, EUROPEAN JOURNAL OF CANCER, Vol: 34, Pages: 437-437, ISSN: 0959-8049
- Author Web Link
- Cite
- Citations: 1
Savage P, Waxman J, 1997, Post-transplantation lymphoproliferative disease, QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, Vol: 90, Pages: 497-503, ISSN: 0033-5622
- Author Web Link
- Cite
- Citations: 25
Nicholson S, Waxman J, 1997, Prostate cancer and endocrine therapy, ENDOCRINE-RELATED CANCER, Vol: 4, Pages: 141-152, ISSN: 1351-0088
- Author Web Link
- Cite
- Citations: 2
Savage P, Bates C, Abel P, et al., 1997, British urological surgery practice .1. Prostate cancer, BRITISH JOURNAL OF UROLOGY, Vol: 79, Pages: 749-754, ISSN: 0007-1331
- Author Web Link
- Cite
- Citations: 24
Fyssas I, Syrigos KN, Konstandoulakis MM, et al., 1997, Sex hormone levels in the serum of patients with pancreatic adenocarcinoma, HORMONE AND METABOLIC RESEARCH, Vol: 29, Pages: 115-118, ISSN: 0018-5043
- Author Web Link
- Cite
- Citations: 25
Waxman J, 1997, Introduction: Basic science aspects of prostate cancer, SEMINARS IN CANCER BIOLOGY, Vol: 8, Pages: 1-1, ISSN: 1044-579X
- Author Web Link
- Cite
- Citations: 1
Bower M, Waxman J, 1997, Gene therapy for prostate cancer, SEMINARS IN CANCER BIOLOGY, Vol: 8, Pages: 3-9, ISSN: 1044-579X
- Author Web Link
- Cite
- Citations: 12
Nightingale J, Koumarinou A, Waxman J, et al., 1997, Integrin profiles of prostatic carcinomas and prostatic cell lines., JOURNAL OF PATHOLOGY, Vol: 181, Pages: A51-A51, ISSN: 0022-3417
Ware MA, Stubbs AP, Bhangal G, et al., 1997, Sequence analysis of the androgen receptor exon 1 CAG trinucleotide repeats in several cell lines (prostatic and non-prostatic) and in microdissected prostatic adenocarcinomas., JOURNAL OF PATHOLOGY, Vol: 181, Pages: A35-A35, ISSN: 0022-3417
Wang O, Lalani EN, Powell S, et al., 1997, FGF8 mRNA expression in benign and malignant prostate - Relationship to androgen receptor status, JOURNAL OF PATHOLOGY, Vol: 181, Pages: A35-A35, ISSN: 0022-3417
Papamichael D, Gallagher CJ, Oliver RTD, et al., 1997, Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureter, BRITISH JOURNAL OF CANCER, Vol: 75, Pages: 606-607, ISSN: 0007-0920
- Author Web Link
- Open Access Link
- Cite
- Citations: 93
Rajkumar T, Stamp GWH, Pandha HS, et al., 1996, Expression of the type 1 tyrosine kinase growth factor receptors EGF receptor, c-erbB2 and c-erbB3 in bladder cancer, JOURNAL OF PATHOLOGY, Vol: 179, Pages: 381-385, ISSN: 0022-3417
- Author Web Link
- Cite
- Citations: 52
Waxman J, Pandha H, 1996, Do we know what's best for prostate cancer?, EUROPEAN JOURNAL OF CANCER, Vol: 32A, Pages: 1455-1456, ISSN: 0959-8049
- Author Web Link
- Cite
- Citations: 2
Stubbs AP, Lalani EN, Stampa GWH, et al., 1996, Second messenger up-regulation of androgen receptor gene transcription is absent in androgen insensitive human prostatic carcinoma cell lines, PC-3 and DU-145 (vol 383, pg 237, 1996), FEBS LETTERS, Vol: 390, Pages: 240-240, ISSN: 0014-5793
Savage P, Waxman J, 1996, PSA and prostate cancer diagnosis, EUROPEAN JOURNAL OF CANCER, Vol: 32A, Pages: 1097-1099, ISSN: 0959-8049
- Author Web Link
- Cite
- Citations: 10
Stubbs AP, Lalani EN, Stamp GWH, et al., 1996, Second messenger up-regulation of androgen receptor gene transcription is absent in androgen insensitive human prostatic carcinoma cell lines, PC-3 and DU-145, FEBS LETTERS, Vol: 383, Pages: 237-240, ISSN: 1873-3468
- Author Web Link
- Cite
- Citations: 22
Stubbs AP, Lalani EN, Stamp GWH, et al., 1996, Erratum: Second messenger up-regulation of androgen receptor gene transcription is absent in androgen insensitive human prostatic carcinoma cell lines, PC-3 and DU-145 (FEBS 16855) (FEBS Letters 383 (1996) 237-240), FEBS Letters, Vol: 390, ISSN: 0014-5793
Pandha HS, Waxman J, 1996, Octreotide in malignant intestinal obstruction, ANTI-CANCER DRUGS, Vol: 7, Pages: 5-10, ISSN: 0959-4973
- Author Web Link
- Cite
- Citations: 8
Syrigos KN, Krausz T, Waxman J, et al., 1995, E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: Correlation with histopathological, grade, tumour stage and survival, INTERNATIONAL JOURNAL OF CANCER, Vol: 64, Pages: 367-370, ISSN: 0020-7136
- Author Web Link
- Cite
- Citations: 107
WAXMAN J, SHEER D, 1995, IS PROSTATE-CANCER WORTH DIAGNOSING, LANCET, Vol: 346, Pages: 1177-1178, ISSN: 0140-6736
- Author Web Link
- Cite
- Citations: 2
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.